In the BioHarmony Drug Report Database
Flunisolide
Aerobid, Aerospan Hfa, Nasalide, Nasarel (flunisolide) is a small molecule pharmaceutical. Flunisolide was first approved as Aerobid on 1982-01-01. It is used to treat allergic rhinitis perennial and asthma in the USA. The pharmaceutical is active against glucocorticoid receptor.
Trade Name
|
Aerobid, Aerospan Hfa, Nasalide, Nasarel |
|---|---|
Common Name
|
flunisolide |
ChEMBL ID
|
CHEMBL1512 |
Indication
|
allergic rhinitis perennial, asthma |
Drug Class
|
Image (chem structure or protein)